GLGlobe Life

$164.26+15% 1Y

$164.26

$129.8152 weeks$186.02

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 10.9 vs a 11.5 median over 41 quarters (−5% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 87% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Globe Life trades at 10.9× earnings against 14.0× for the median Insurance - Life name, cheaper than its own group.

10.9

Trailing P/E · Insurance - Life median 14.0 · cheaper than the typical name in its group

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $15.07 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$138.87
Its own P/E history, median	$173.34
Its own P/E history, upper quartile	$197.07
52-week range	$129.81 – $186.01
Today	$164.26

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

The closest names by size in the same industry